Dr. David Schmerler, DO
NPI: 1760707574
Total Payments
$156,245
2024 Payments
$6,857
Companies
58
Transactions
636
Medicare Patients
2,929
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$134,506 (86.1%)
Food & Beverage$14,824 (9.5%)
Travel$4,784 (3.1%)
Consulting$2,107 (1.3%)
Education$24.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $126,981 | 81 | 81.3% |
| Food and Beverage | $14,824 | 501 | 9.5% |
| Honoraria | $7,525 | 3 | 4.8% |
| Travel and Lodging | $4,784 | 45 | 3.1% |
| Consulting Fee | $2,107 | 3 | 1.3% |
| Education | $24.42 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $64,865 | 87 | $0 (2024) |
| Acorda Therapeutics, Inc | $44,844 | 79 | $0 (2021) |
| Allergan, Inc. | $11,512 | 65 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $6,369 | 7 | $0 (2021) |
| Lundbeck LLC | $5,105 | 24 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $5,037 | 19 | $0 (2021) |
| CATALYST PHARMACEUTICALS, INC. | $3,820 | 7 | $0 (2019) |
| Abbott Laboratories | $2,705 | 16 | $0 (2023) |
| Adamas Pharmaceuticals, Inc. | $2,494 | 3 | $0 (2021) |
| GENZYME CORPORATION | $1,254 | 33 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,857 | 22 | ABBVIE INC. ($6,303) |
| 2023 | $10,859 | 26 | AbbVie Inc. ($10,200) |
| 2022 | $22,044 | 35 | ABBVIE INC. ($21,524) |
| 2021 | $48,829 | 65 | AbbVie Inc. ($26,692) |
| 2020 | $19,809 | 66 | Acorda Therapeutics, Inc ($9,207) |
| 2019 | $39,979 | 178 | Acorda Therapeutics, Inc ($33,508) |
| 2018 | $5,333 | 133 | Abbott Laboratories ($2,398) |
| 2017 | $2,534 | 111 | GENZYME CORPORATION ($578.20) |
All Payment Transactions
636 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $9.96 | General |
| 10/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $120.55 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $9.44 | General |
| 10/15/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROLOGY | ||||||
| 08/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROLOGY | ||||||
| 08/05/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $70.42 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: Neurology | ||||||
| 04/24/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: NEUROLOGY | ||||||
| 02/26/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROLOGY | ||||||
| 02/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $136.86 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/02/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $129.89 | General |
| Category: Neuroscience | ||||||
| 11/01/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $120.08 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 765 | 21,011 | $961,200 | $256,478 |
| 2022 | 15 | 724 | 21,123 | $1.1M | $290,675 |
| 2021 | 9 | 700 | 17,686 | $612,709 | $178,083 |
| 2020 | 17 | 740 | 35,121 | $3.2M | $830,911 |
Total Patients
2,929
Total Services
94,941
Medicare Billing
$1.6M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 17,614 | $286,838 | $82,607 | 28.8% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 11 | 2,410 | $289,200 | $67,487 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 370 | $112,480 | $33,093 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 190 | 190 | $111,720 | $30,317 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 137 | 192 | $78,528 | $24,703 | 31.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 14 | 46 | $33,700 | $7,372 | 21.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 33 | $19,239 | $4,371 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 48 | $9,840 | $3,147 | 32.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 27 | 38 | $8,550 | $1,440 | 16.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 13 | $6,500 | $1,171 | 18.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 19 | $2,166 | $341.65 | 15.8% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 11 | 23 | $1,449 | $264.97 | 18.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 12 | 15 | $990.00 | $163.64 | 16.5% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 12 | 4,150 | $498,000 | $125,233 | 25.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 26 | 16,000 | $256,000 | $73,346 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 338 | $102,752 | $30,344 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 155 | 155 | $91,140 | $23,725 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 97 | 117 | $47,853 | $14,305 | 29.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 14 | 42 | $30,710 | $6,904 | 22.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $19,822 | $5,327 | 26.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 11 | 30 | $13,500 | $3,367 | 24.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 35 | 75 | $16,875 | $3,112 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 42 | $8,610 | $2,395 | 27.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 12 | 13 | $6,500 | $1,124 | 17.3% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 17 | 55 | $3,465 | $759.30 | 21.9% |
About Dr. David Schmerler, DO
Dr. David Schmerler, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1760707574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Schmerler, DO has received a total of $156,245 in payments from pharmaceutical and medical device companies, with $6,857 received in 2024. These payments were reported across 636 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($126,981).
As a Medicare-enrolled provider, Schmerler has provided services to 2,929 Medicare beneficiaries, totaling 94,941 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Cincinnati, OH
- Active Since 04/05/2010
- Last Updated 01/30/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1760707574
Products in Payments
- UBRELVY (Drug) $47,949
- INBRIJA (Drug) $44,470
- QULIPTA (Drug) $22,446
- NURTEC ODT (Drug) $6,369
- BOTOX (Biological) $5,572
- VYEPTI (Biological) $4,712
- KYNMOBI (Drug) $4,565
- GOCOVRI (Drug) $2,614
- Neuromodulation Dspsbls and Accs (Device) $1,651
- Infinity DBS Pulse Generators (Device) $811.60
- Briviact (Drug) $602.32
- ACTIVA (Device) $571.16
- RYTARY (Drug) $553.15
- AUSTEDO (Drug) $521.46
- Epidiolex (Drug) $386.27
- TECFIDERA (Drug) $372.43
- AUBAGIO (Drug) $367.68
- APTIOM (Drug) $348.18
- Nourianz (Drug) $280.49
- NUPLAZID (Drug) $277.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Cincinnati
Raviteja Guddeti, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $65,053
Student in an Organized Health Care Education/Training Program $65,053
Andrew Kalthoff, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $44,942
Student in an Organized Health Care Education/Training Program $44,942
Christopher Paprzycki, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $38,190
Student in an Organized Health Care Education/Training Program $38,190
Trisha Wise-Draper, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $29,228
Student in an Organized Health Care Education/Training Program $29,228
Kathryn Weaver, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $18,701
Student in an Organized Health Care Education/Training Program $18,701
Saad Hasan
Student in an Organized Health Care Education/Training Program — Payments: $18,307
Student in an Organized Health Care Education/Training Program $18,307